How to buy Asensus Surgical stock (TRXC)

Asensus Surgical is a medical devices business based in the US. Asensus Surgical shares (TRXC) are listed on the NYSE MKT and all prices are listed in US Dollars. Asensus Surgical employs 160 staff and has a trailing 12-month revenue of around $2.8 million.

Our top picks for where to buy Asensus Surgical stock

Buy Asensus Surgical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Asensus Surgical stock price (NYSE MKT: TRXC)

Use our graph to track the performance of TRXC stocks over time.

Asensus Surgical shares at a glance

• Key figures

Information last updated 2021-05-06.

52-week range	$0.00 - $0.00
50-day moving average more info button	$4.29
200-day moving average more info button	$1.62
Wall St. target price	$1.45
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.34

Is it a good time to buy Asensus Surgical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Asensus Surgical financials

Revenue TTM	$2.8 million
Gross profit TTM	$-4,792,000
Return on assets TTM	-44.58%
Return on equity TTM	-94.1%
Profit margin	0%
Book value	$0.62
Market Capitalization more info button	$916.9 million

TTM: trailing 12 months

Asensus Surgical share dividends

We're not expecting Asensus Surgical to pay a dividend over the next 12 months.

Have Asensus Surgical's shares ever split?

Asensus Surgical's shares were split on a 1:13 basis on 11 December 2019 . So if you had owned 13 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Asensus Surgical shares – just the quantity. However, indirectly, the new 1200% higher share price could have impacted the market appetite for Asensus Surgical shares which in turn could have impacted Asensus Surgical's share price.

Asensus Surgical share price volatility

Over the last 12 months, Asensus Surgical's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Asensus Surgical's is 1.9772. This would suggest that Asensus Surgical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Asensus Surgical overview

Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. The company's digital interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's products include Senhance Surgical System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and internationally. The company was formerly known as TransEnterix, Inc.

Frequently asked questions

What percentage of Asensus Surgical is owned by insiders or institutions?
Currently 4.05% of Asensus Surgical shares are held by insiders and 25.148% by institutions. How many people work for Asensus Surgical?
Latest data suggests 160 work at Asensus Surgical. When does the fiscal year end for Asensus Surgical?
Asensus Surgical's fiscal year ends in December. Where is Asensus Surgical based?
Asensus Surgical's address is: 635 Davis Drive, Morrisville, NC, United States, 27560 What is Asensus Surgical's ISIN number?
Asensus Surgical's international securities identification number is: US89366M3007 What is Asensus Surgical's CUSIP number?
Asensus Surgical's Committee on Uniform Securities Identification Procedures number is: 151167301